Project Results for Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
Project: Measuring Analytes in Maternal Archived Samples (MAMAS) – MAMAS 2
- Study Group: 540 pregnant individuals
- Sample Collection Date: -
Chemical Group: Organochlorine Pesticides
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| beta-Hexachlorocyclohexane (beta-HCH) | b-HCH | ng/g lipid | 242 | * | * | * | <LOD | 3.05 | 4.39 | 7.84 | 64.5% | 0.0160 and 0.0180 ng/mL** |
| DDE (para,para) | para,para-DDT and/or para,para-DDE | ng/g lipid | 242 | 47.6 | 42.6 | 53.3 | 29.0 | 41.4 | 65.8 | 221 | 100% | 0.0181 and 0.0359 ng/mL** |
| DDT (ortho,para) | ortho,para-DDT | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 and 0.0180 ng/mL** |
| DDT (para,para) | para,para-DDT | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 2.98 | 9.1% | 0.0160 and 0.0180 ng/mL** |
| Hexachlorobenzene (HCB) | HCB | ng/g lipid | 242 | 11.4 | 10.8 | 11.9 | 8.98 | 11.2 | 13.5 | 21.7 | 93.4% | 0.0399 and 0.0875 ng/mL** |
| Oxychlordane | Chlordane | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.5% | 0.0160 and 0.0180 ng/mL** |
| trans-Nonachlor | Chlordane | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 2.18 | 24.4% | 0.0160 and 0.0180 ng/mL** |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- **LOD changed during the time that samples were analyzed for this project.
Chemical Group: Perfluoroalkyl and Polyfluoroalkyl Substances (PFASs)
- Measured in: Serum
- Study Group Subset: Subsample 2
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| 4:2 FTS | 4:2 FTS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0463 | 6.2% | 0.0372 ng/mL |
| 5:3 FTCA | 5:3 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0500 ng/mL |
| 6:2 diPAP | 6:2 diPAP | ng/mL | 277 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.5% | 0.0645 ng/mL |
| 6:2 FTCA | 6:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 6:2 FTS | 6:2 FTS | ng/mL | 240 | * | * | * | <LOD | <LOD | <LOD | 0.781 | 20.8% | 0.188 ng/mL |
| 6:2 FTUCA | 6:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0243 ng/mL |
| 6:6 PFPiA | 6:6 PFPiA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0429 ng/mL |
| 7:3 FTCA | 7:3 FTCA | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 4.8% | 0.0622 ng/mL |
| 8:2 diPAP | 8:2 diPAP | ng/mL | 291 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/ml |
| 8:2 FTCA | 8:2 FTCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.250 ng/mL |
| 8:2 FTS | 8:2 FTS | ng/mL | 290 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.4% | 0.0500 ng/mL |
| 8:2 FTUCA | 8:2 FTUCA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.3% | 0.0280 ng/mL |
| Et-PFOSA-AcOH | Et-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0179 | 0.0398 | 35.6% | 0.0131 ng/mL |
| Me-PFOSA-AcOH | Me-PFOSA-AcOH | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.107 | 0.287 | 45.5% | 0.0638 ng/mL |
| PFBA | PFBA | ng/mL | 292 | 0.0577 | 0.0550 | 0.0606 | <LOD | 0.0594 | 0.0770 | 0.121 | 65.8% | 0.0500 ng/mL |
| PFBS | PFBS | ng/mL | 292 | * | * | * | <LOD | <LOD | 0.0119 | 0.0283 | 25.0% | 0.0140 ng/mL |
| PFDA | PFDA | ng/mL | 292 | 0.213 | 0.196 | 0.231 | 0.135 | 0.189 | 0.320 | 0.752 | 99.0% | 0.0542 ng/mL |
| PFDoA | PFDoA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0854 | 16.4% | 0.0500 ng/mL |
| PFDS | PFDS | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0308 | 5.8% | 0.0274 ng/mL |
| PFHpA | PFHpA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.103 | 24.0% | 0.0500 ng/ml |
| PFHxA | PFHxA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0925 | 5.5% | 0.0818 ng/mL |
| PFHxPA | PFHxPA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0% | 0.0500 ng/mL |
| PFHxS | PFHxS | ng/mL | 292 | 0.743 | 0.690 | 0.800 | 0.496 | 0.720 | 1.00 | 2.66 | 100% | 0.0195 ng/ml |
| PFNA | PFNA | ng/mL | 292 | 0.542 | 0.509 | 0.578 | 0.372 | 0.527 | 0.774 | 1.39 | 100% | 0.0487 ng/mL |
| PFOA | PFOA | ng/mL | 292 | 1.01 | 0.942 | 1.09 | 0.631 | 1.02 | 1.55 | 2.88 | 100% | 0.0539 ng/mL |
| PFOS | PFOS | ng/mL | 292 | 3.10 | 2.88 | 3.33 | 2.05 | 3.09 | 4.41 | 9.07 | 100% | 0.316 ng/mL |
| PFOSA | PFOSA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.4% | 0.0173 ng/mL |
| PFPeA | PFPeA | ng/mL | 292 | * | * | * | <LOD | <LOD | <LOD | 0.0255 | 6.5% | 0.0235 ng/mL |
| PFUnDA | PFUnDA | ng/mL | 292 | 0.129 | 0.115 | 0.145 | 0.0646 | 0.118 | 0.275 | 0.726 | 81.2% | 0.0481 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polybrominated Diphenyl Ethers (PBDEs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| BDE 017 | BDE 17 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0160 ng/mL |
| BDE 028 | BDE 28 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.0160 ng/mL |
| BDE 047 | BDE 47 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 13.6 | 33.4 | 46.5% | 0.0640 ng/mL |
| BDE 066 | BDE 66 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 ng/mL |
| BDE 085 | BDE 85 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0160 ng/mL |
| BDE 099 | BDE 99 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 4.97 | 11.5 | 26.9% | 0.0350 ng/mL |
| BDE 100 | BDE 100 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | 3.59 | 8.99 | 46.5% | 0.0160 ng/mL |
| BDE 153 | BDE 153 | ng/g lipid | 245 | * | * | * | <LOD | 6.68 | 11.3 | 25.2 | 58.4% | 0.0320 ng/mL |
| BDE 154 | BDE 154 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.0320 ng/mL |
| BDE 183 | BDE 183 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
| BDE 196 | BDE 196 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0320 ng/mL |
| BDE 197 | BDE 197 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.0320 ng/mL |
| BDE 201 | BDE 201 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
| BDE 202 | BDE 202 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0320 ng/mL |
| BDE 203 | BDE 203 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0320 ng/mL |
| BDE 206 | BDE 206 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0400 ng/mL |
| BDE 207 | BDE 207 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.9% | 0.0400 ng/mL |
| BDE 208 | BDE 208 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.6% | 0.0400 ng/mL |
| BDE 209 | BDE 209 | ng/g lipid | 245 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.0% | 0.300 ng/mL |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
Chemical Group: Polychlorinated Biphenyls (PCBs)
- Measured in: Serum
- Study Group Subset: Subsample 1
Unweighted Results
| Chemical measured | Indicates Exposure to | Units | Number of people tested | Geometric mean | 95% Confidence Interval | Selected Percentiles | Detection Frequency | Limit of Detection (LOD), wet-weight | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | 25th | 50th | 75th | 95th | |||||||
| PCB 066 | PCB 66 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.2% | 0.0160 and 0.0180 ng/mL** |
| PCB 074 | PCB 74 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 1.7% | 0.0160 and 0.0180 ng/mL** |
| PCB 099 | PCB 99 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 3.3% | 0.0160 and 0.0180 ng/mL** |
| PCB 101 | PCB 101 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.8% | 0.0160 and 0.0180 ng/mL** |
| PCB 105 | PCB 105 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 0.8% | 0.0160 and 0.0180 ng/mL** |
| PCB 118 | PCB 118 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.03 | 16.9% | 0.0160 and 0.0180 ng/mL** |
| PCB 138 | PCB 138 | ng/g lipid | 242 | * | * | * | <LOD | 2.50 | 3.45 | 5.80 | 56.2% | 0.0160 and 0.0180 ng/mL** |
| PCB 153 | PCB 153 | ng/g lipid | 242 | 3.16 | 2.93 | 3.41 | <LOD | 2.89 | 4.41 | 8.25 | 65.3% | 0.0160 and 0.0180 ng/mL** |
| PCB 156 | PCB 156 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0160 and 0.0180 ng/mL** |
| PCB 170 | PCB 170 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.64 | 18.2% | 0.0160 and 0.0180 ng/mL** |
| PCB 180 | PCB 180 | ng/g lipid | 242 | * | * | * | <LOD | 2.66 | 4.04 | 8.43 | 59.9% | 0.0160 and 0.0180 ng/mL** |
| PCB 183 | PCB 183 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 2.1% | 0.0160 and 0.0180 ng/mL** |
| PCB 187 | PCB 187 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | 3.29 | 11.6% | 0.0160 and 0.0180 ng/mL** |
| PCB 194 | PCB 194 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | <LOD | <LOD | 5.0% | 0.0160 and 0.0180 ng/mL** |
| PCB 203 | PCB 203 | ng/g lipid | 242 | * | * | * | <LOD | <LOD | 2.69 | 4.35 | 26.9% | 0.0173 and 0.0188 ng/mL** |
Footnotes
- *Geometric mean was not calculated because the chemical was found in less than 65% of the study group.
- **LOD changed during the time that samples were analyzed for this project.